Corporate Details

Sosei Group Corporation

Established

June 22, 1990

Capital

36,854 million yen (as of end of December 2018)

Scope of business

Planning strategy for the entire Group and managing subsidiary companies

Representative Executive Officer, Chairman, President and Chief Executive Officer

Shinichi Tamura

Securities code

4565-JP

Accounting period

12 months ended 31 December

Number of employees

171 (consolidated figure, as of end of December 2018)

Corporate headquarters

PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan

Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291

Group Companies

Heptares Therapeutics Ltd

Capital

JPY 45,525,238

Scope of Business

Drug discovery based on targeting of G protein-coupled receptors

Representative Director

Malcolm Weir

Holding Company Stake

100%

Address

Steinmetz Building, Granta Park
Great Abington,
Cambridge CB21 6GT
United Kingdom
Tel: +44 (0)1223 949 100

Sosei Co. Ltd

Capital

JPY 90,000,000

Scope of Business

Drug development and sales, business development in Japan

Representative Director

Tadayoshi Yasui

Holding Company Stake

100% (voting rights)

Address

PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan (map)
Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291

Sosei CVC Ltd

Capital

JPY 35,000,000

Scope of Business

Managing Sosei RMF1 (Regenerative Medicine Fund)

Representative Director

Yoshihiro Minami

Holding Company Stake

90%

Address

PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan (map)
Tel: +81-(0)3-6679-2044 (general enquiries)
Fax: +81-(0)3-5210-3291